(Q38091562)

28 August 2017

title

How to use ambulatory blood pressure monitoring in resistant hypertension (English)

1 reference

28 August 2017

Elizabeth S Muxfeldt

1

1 reference

28 August 2017

Gil F Salles

series ordinal

2

1 reference

28 August 2017

publication date

21 March 2013

1 reference

28 August 2017

published in

Hypertension Research

1 reference

28 August 2017

volume

36

1 reference

28 August 2017

issue

5

1 reference

28 August 2017

page(s)

385-389

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2013.17

28 August 2017

exact match

0 references

cites work

2007 Guidelines for the Management of Arterial Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

Prognostic influence of office and ambulatory blood pressures in resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

True resistant hypertension: is it possible to be recognized in the office?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

Ambulatory blood pressure monitoring in resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

New developments in the diagnosis and management of resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

Circadian variation of blood pressure: the basis for the chronotherapy of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

Effects of time of antihypertensive treatment on ambulatory blood pressure and clinical characteristics of subjects with resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

Pulse pressure or dipping pattern: which one is a better cardiovascular risk marker in resistant hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

A blunted decrease in nocturnal blood pressure is independently associated with increased aortic stiffness in patients with resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

Prognostic factors in resistant hypertension: implications for cardiovascular risk stratification and therapeutic management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

Efficacy of spironolactone therapy in patients with true resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

Prognostic value of nocturnal blood pressure reduction in resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

7 January 2021

Characteristics of resistant hypertension determined by self-measured blood pressure at home and office blood pressure measurements: the J-HOME study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

7 January 2021

Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

7 January 2021

White-coat resistant hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

7 January 2021

Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

7 January 2021

Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

7 January 2021

Managing resistant hypertension: not just a question of numbers

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

7 January 2021

Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

7 January 2021

Urinary Albumin Excretion Is Associated With Nocturnal Systolic Blood Pressure in Resistant Hypertensives

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

7 January 2021

Prognostic impact of the ambulatory arterial stiffness index in resistant hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

7 January 2021

Home versus ambulatory blood pressure monitoring in the diagnosis of clinic resistant and true resistant hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

7 January 2021

[Assessment of resistant hypertension with home blood pressure monitoring]

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

7 January 2021

Effect of spironolactone on blood pressure in subjects with resistant hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.17

7 January 2021

Identifiers

DOI

10.1038/HR.2013.17

1 reference

28 August 2017

1 reference